| Financial Year |
March 31 2023 |
| Monetary Funds |
151,794,921.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
65,970,290.81 |
| Advances to Suppliers |
3,863,979.08 |
| Other Receivables |
5,011,543.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
166,915.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
249,625.57 |
| Total Current Assets |
227,057,276.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
18,052,013.90 |
| Fixed Assetes |
2,218,415.84 |
| Under-construction Projects |
446,748.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
627,271.24 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,443,099.86 |
| Deferred Income Tax Assets |
907,237.04 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
26,704,791.48 |
| Total Assets |
253,762,068.08 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
11,872,621.51 |
| Accounts Received In Advance |
30,291.52 |
| Employee Compensation Payable |
13,636,113.92 |
| Taxes Payable |
11,677,803.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,761,039.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,335,313.23 |
| Other Current Liabilities |
2,660,374.64 |
| Sub-Total of Current Liabilities |
131,791,386.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,402.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,720,465.46 |
| Total Liabilities |
133,511,852.41 |
| Paid-In Capital(Or Share Stock) |
292,538,575.00 |
| Capital Surplus |
1,733,870,233.73 |
| Surplus Reserve |
9,282,718.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,915,882,007.97 |
| Minority Stockholder's Interest |
440,696.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
119,809,519.52 |
| Owner's Equity（Stockholder's Equity） |
120,250,215.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
253,762,068.08 |
